• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eton Pharmaceutcials Inc (NQ: ETON )

    3.280 -0.040 (-1.20%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Jun 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Eton Pharmaceutcials Inc

    < Previous 1 2 3 4 5 Next >
    ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
    ETON stock results show that Eton Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Recap: Eton Pharmaceuticals Q4 Earnings
    Via Benzinga
    Eton Pharmaceuticals Earnings Preview
    Via Benzinga
    Is NASDAQ:ETON suited for growth investing?
    ETON PHARMACEUTICALS INC (NASDAQ:ETON) may be suited for growth investing, we'll explore why in this article. 
    Via Chartmill
    Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
    From Eton Pharmaceuticals
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
    From Eton Pharmaceuticals
    Via GlobeNewswire
    ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
    ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Why the growth investor may take a look at NASDAQ:ETON.
    Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
    Via Chartmill
    Evaluating NASDAQ:ETON for Growth Investment Opportunities.
    Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics. 
    Via Chartmill
    Eton Pharmaceuticals: Q3 Earnings Insights
    Via Benzinga
    Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Earnings Scheduled For March 14, 2024
    Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
    Via Benzinga
    Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Gilead Sciences Tops Q3 Earnings And Revenue Estimates
    While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? 
    Via Talk Markets
    Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
    U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    FSR Stock Alert: What to Know About the New Fisker Ronin EV
    Fisker (FSR) stock is in the news Friday after the company provided customers with more details about the upcoming Fisker Ronin Super GT EV. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Is Cano Health (CANO) Stock Down 48% Today?
    Cano Health (CANO) stock is taking a beating on Friday after the healthcare company provided a business update in its latest earnings report. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.